Skip to main content

Pharmaceutical Industries in Hyderabad, Andhra Pradesh.


Dr.Reddy's Laboratories Ltd
Corporate Office
Dr. Reddy's Laboratories Limited
Door No 8-2-337, Road No 3, Banjara Hills, Hyderabad - 500034. Andhra Pradesh.India
Tel: +91-40-49002900
Fax: +91-40-49002999
Visit: www.drreddys.com

AUROBINDO PHARMA
Registered & Corporate Office
Plot # 2, Maitri Vihar, Ameerpet, Hyderabad - 500 038, Andhra Pradesh, India.
Phone: +91 (40) 6672 5000
Fax:+91 (40) 2374 1080 / +91 (40) 2374 6833,
Email : info@aurobindo.com

NATCO PHARMA LIMITED
NATCO HOUSE
Road No.2, Banjara Hills Hyderabad-500 033
+91-40-2354 7532
+91-40-2354 5298/23548243
natinfo@natcopharma.co.in
www.natcopharma.co.in

MYLAN LABORATORIES LIMITED
Plot No 564/A/22, Road No 92, Jubilee Hills,  Hyderabad — 500034
Phone:     +91.40.30866666
                  +91.40.23550543
Fax:           +91.40.30866699
Email: matrix@mylan.in

HETERO DRUGS LIMITED
7-2-A2, HETERO CORPORATE
INDUSTRIAL ESTATES. SANATH NAGAR HYDERABAD – 500 018. A.P. INDIA
Tel :  +91 40 23704923 / 24 / 25 / 26 / 27 / 28
          +91 40 23707171 / 7272 / 7744
Fax : +91 40 23714250 / 2370 4926
Email: contact@heterodrugs.com

INDIAN IMMUNOLOGICALS Ltd.
Corporate Office 
Road # 44, Jubilee Hills, Hyderabad - 500033
Andhra Pradesh, India
E-mail: info@indimmune.com
Tel : +91 40 23544585
        +91 40 23544593
        +91 9948298322
        +91 9948298422
Fax: +91 40 23544007

Gland Pharma Limited
Business Development Department
6-3-865/1/2, Flat No 201,
Green Land Apartments, Ameerpet, Hyderabad - 500 016. INDIA
Ph# +91 40 66621010,
Fax# +91 40 23402229,
Email: gland@glandpharma.com

Neuland Laboratories

Corporate Office

204, Meridian Plaza, 6-3-854/1, Ameerpet, Hyderabad – 500 016, A.P. India.
Phone  : +91-40-30211600, +91-40-23412934
Fax      : +91-40-23412957
E-mail  : neuland@neulandlabs.com

Divis laboratories
http://www.divislabs.com/home.asp

Granules
http://www.granulesindia.com/Sales_offices.aspx#india

Shantha biotech
http://www.shanthabiotech.com/index.html



Labels:

Comments

Post a Comment

Popular posts from this blog

Pharma Companies HR contact information

Dear viewers of my blog, I am happy to share the HR contact details of Pharmaceutical companies. Contact Details Of Pharma HRs : Zaydus cadila-Goa gajendravernekar@zayduscadila.com 09623458512/08326615143 Teva-Goa Maryann.Braganza@teva.co.in sanjay.pandit@teva.co.in 0832 6685538 Glenmark-Goa Vittal hebbalkar hr executivr - 9923476869 anupbannatti@glenmark-generics.com 09604151586 Watson-Goa Jyosna.bagule@watsonpharm.co.in runa.divkar@watsonpharm.co.in goa@watsonpharm.co.in 0832 6690666/777 Unichem Labs-Goa abhiram.panshikar@unichemlabs.com R&D  suraj.jadhav@unichemlabs.com vikas.parkar@unichemlabs.com Indico-Goa goahplc@Indoco.com varun.keny@indoco.com anand.ingole@Indoco.com 0832 6624109 Encube-Goa hr@encubeethicals.com nidhi.b@encubeethicals.com 8322392223 Torrent pharma-Ahmdabad mayurdesai@torrentpharma.com 9879603921/22/23/24 Emcure-pune RPKulkarni@emcure.co.in           Kishor.Mule@emcure.co.in Rahul.Morgaonkar@emcure.co.in recruitment@em
1 comment
Read more

DoE - Doctrine of Equivalents

The Doctrine of Equivalents is a legal principle that is relevant to patent law, particularly in the United States, and it helps protect inventors' rights even when minor changes or substitutions have been made to a patented invention.  When an inventor applies for a patent, the claims in the patent document define the scope of protection for the invention. These claims outline the specific elements or features of the invention that are considered unique and non-obvious. If another party copies or uses the patented invention without permission, it may be considered infringement. However, in some cases, the accused infringer may make slight modifications to the invention that fall outside the literal scope of the patented claims. The Doctrine of Equivalents comes into play here. It allows the patent holder to assert that the accused infringer's modified version is still equivalent to the patented invention and, therefore, falls within the scope of the patent protection. For the
Post a Comment
Read more

Competitive Landscape for Pharmaceutical Generic products.

Creating a competitive landscape for a pharmaceutical generic product involves analyzing the market and identifying key players, their strengths, weaknesses, and market positioning. Here's a simplified outline: **Competitive Landscape Analysis for Pharmaceutical Generic Product:** 1. **Market Overview:**    - Size of the pharmaceutical generic product market.    - Growth trends and forecasts.    - Regulatory environment and barriers to entry. 2. **Key Players:**    - List the major pharmaceutical companies producing the generic product.    - Include both global and regional players. 3. **Market Share:**    - Percentage of market share held by each major player.    - Trends in market share changes over time. 4. **Product Portfolio:**    - Types of generic products offered by each player.    - Variations in strengths, dosage forms, and delivery methods. 5. ** Competitive Advantage :**    - Identify unique selling points of each player's products.    - Cost advantages, manufacturi
Post a Comment
Read more